FDA Approved: CALCITRIOL — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved an original Abbreviated New Drug Application for calcitriol by Rising Pharma Holdings, Inc., providing a generic version of the vitamin D analog.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism Due to Chronic Kidney Disease
• Hypoparathyroidism

Drugs mentioned

• Calcitriol (calcitriol)

Snippet

ORIG AP for CALCITRIOL (CALCITRIOL)